Tashkent, Uzbekistan (UzDaily.com) -- A meeting of the Interstate Commission on standardization, registration and quality control of medicines, medical devices and medical equipment of the CIS member states was held on 27 June. This was reported by the press service of the CIS Executive Committee.

The meeting was attended by representatives of Belarus, Kyrgyzstan, Russia, Tajikistan, Uzbekistan, the Inter-Parliamentary Assembly of States - Members of the CIS and the Executive Committee of the Commonwealth.

During the meeting, members of the Commission emphasized that drug provision is one of the most important social guarantees and a very significant component of the availability and quality of medical care provided to the population in the CIS countries. In this regard, cooperation in this area is of particular importance and relevance. A vivid confirmation of this is the interaction during the COVID-19 pandemic. To ensure the availability of medical care to citizens of the Commonwealth countries, Russian vaccines against a new coronavirus infection were registered in a short time, production was organized and their access to the population was organized.

The meeting participants discussed proposals for inclusion in the work plan for 2023-2024, while noting the need to consolidate efforts to update the Agreement on Cooperation in Combating the Circulation of Counterfeit Medicines of November 14, 2008 and the Agreement on Providing the Population with Medicines, Vaccines and Other Immunobiological Products preparations, medical devices and medical equipment manufactured on the territory of the CIS member states dated December 24, 1993.

Suggestions were made on the advisability of discussing the issues of registration of medicines and medical devices in countries, production and use of radiopharmaceuticals, harmonization of requirements for registration of medicines, medical devices and medical equipment, and a number of others.

Representatives of the IPA CIS briefed the meeting participants on the progress of work on the preparation of the draft model law “On Drug Provision”, noting that on June 30, 2023, the first expert discussion of this document will take place in Minsk. Representatives of the parliaments of the member states of the Commonwealth, the Expert Council on Health under the IPA CIS, relevant international organizations and the academic community will take part in the work.

The next meeting of the Interstate Commission for Standardization, Registration and Quality Control of Medicines, Medical Devices and Medical Equipment is planned to be held in the third quarter of this year.

It should be noted that the interaction of the CIS member states on the issues of drug supply has been built since the establishment of the Council for Cooperation in the field of health care of the Commonwealth of Independent States. To interact at the expert level and promote cooperation between countries in improving and further deepening cooperation in the field of circulation of medicines, medical devices and medical equipment, developing integration in the field of their standardization, registration and quality control, a special working body was created.